HCW Biologics Inc.
HCWB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828673
In the last 90 days, HCW Biologics Inc. insiders filed 3 open-market purchases and 0 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $515.7K in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in HCW Biologics Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +1 vs. Q4 2023
- Shares held
- 1.10M
- +35.1K (+3.3%) vs. Q4 2023
- Total value
- $1.90M
- +$597.6K (+45.9%) vs. Q4 2023
- New holders
- 3
- 4 more added
- Sold out
- 2
- 6 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HCWB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $515.7K |
| Q1 2026 | 15 | $160.8K |
| Q4 2025 | 14 | $424.1K |
| Q3 2025 | 10 | $456.9K |
| Q2 2025 | 8 | $85.5K |
| Q1 2025 | 15 | $326.0K |
| Q4 2024 | 18 | $1.40M |
| Q3 2024 | 16 | $625.6K |
| Q2 2024 | 19 | $784.3K |
| Q1 2024 | 20 | $1.90M |
| Q4 2023 | 19 | $1.30M |
| Q3 2023 | 14 | $1.93M |
| Q2 2023 | 13 | $2.17M |
| Q1 2023 | 13 | $1.22M |
| Q4 2022 | 14 | $1.50M |
| Q3 2022 | 13 | $1.50M |
| Q2 2022 | 13 | $1.25M |
| Q1 2022 | 13 | $1.48M |
| Q4 2021 | 13 | $855.0K |
| Q3 2021 | 9 | $512.0K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding HCW Biologics Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HighTower Advisors, LLC | 179,810 | $316.0K | 0.00% | 00.0% | Unchanged |
| Avantax Planning Partners, Inc. | 179,777 | $314.6K | 0.01% | +236+0.1% | Added |
| Geode Capital Management, LLC | 174,284 | $291.1K | 0.00% | +39,848+29.6% | Added |
| Cresset Asset Management, LLC | 131,990 | $231.0K | 0.00% | 00.0% | Unchanged |
| Pullen Investment Management, LLC | 85,116 | $149.0K | 0.13% | +85,116 | New |
| Bridgeway Capital Management, LLC | 84,700 | $141.4K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 73,113 | $122.0K | 0.00% | +73,113 | New |
| BlackRock Inc. | 46,034 | $80.6K | 0.00% | −1,124−2.4% | Reduced |
| Vanguard Group Inc | 37,649 | $65.9K | 0.00% | −167,493−81.6% | Reduced |
| AE Wealth Management LLC | 30,000 | $52.5K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 22,640 | $39.6K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 21,446 | $35.8K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 17,247 | $30.2K | 0.00% | +17,247 | New |
| Northern Trust Corp | 10,205 | $17.9K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,938 | $8.64K | 0.00% | −731−12.9% | Reduced |
| UBS Group AG | 605 | $1.06K | 0.00% | −30−4.7% | Reduced |
| Bank of America Corp | 406 | $710 | 0.00% | +395+3,590.9% | Added |
| Wells Fargo & Company | 141 | $247 | 0.00% | +3+2.2% | Added |
| JPMorgan Chase & Co | 9 | $15 | 0.00% | −74−89.2% | Reduced |
| Royal Bank of Canada | 244 | $0 | 0.00% | −52−17.6% | Reduced |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −10,351−100.0% | Sold out |
| Focused Wealth Management, Inc | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |